Context Therapeutics (CNTX) Earnings Date & Reports

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CNTX is expected to report earnings to rise 300.00% to -11 cents per share on May 07

Context Therapeutics CNTX Stock Earnings Reports

Q1'25

Est.

$-0.12

Q4'24

Beat

by $0.03

Q3'24

Missed

by $0.17

Q2'24

Beat

by $0.03

Q1'24

Beat

by $0.09

The last earnings report on March 20 showed earnings per share of -2 cents, beating the estimate of -5 cents. With 68.94K shares outstanding, the current market capitalization sits at 60.10M.

View a ticker or compare two or three

Compare

CNTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For CNTX
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

2001 Market Street

Phone

+1 267 225-7416

Employees

Web

https://www.contexttherapeutics.com